Incyte's experimental skin disease drug met the main goal of two separate late-stage trials, the company said on Monday, but its shares declined 11% as the drug significantly underperformed prior ...

Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

Cosentyx (secukinumab ... always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended ...

A comparative study will be conducted to demonstrate the efficacy, safety, and equivalence between Cosentyx and CT-P55. CT-P55 received IND approval from the U.S. Food and Drug Administration (FDA ...